{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T02:47:27Z","timestamp":1787194047786,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.vaccine.2011.04.027","type":"journal-article","created":{"date-parts":[[2011,4,25]],"date-time":"2011-04-25T11:10:40Z","timestamp":1303729840000},"page":"4302-4307","source":"Crossref","is-referenced-by-count":9,"title":["Vaccination of guinea pigs using mce operon mutants of Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"29","author":[{"given":"Andr\u00e9s","family":"Obreg\u00f3n-Henao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal","family":"Shanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Ver\u00f3nica","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel A.","family":"Cataldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall J.","family":"Basaraba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Orme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Bigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.vaccine.2011.04.027_bib0005","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2471\/BLT.08.058453","article-title":"Trends in tuberculosis incidence and their determinants in 134 countries","volume":"87","author":"Dye","year":"2009","journal-title":"Bull World Health Organ"},{"issue":"5980","key":"10.1016\/j.vaccine.2011.04.027_bib0010","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1185449","article-title":"The population dynamics and control of tuberculosis","volume":"328","author":"Dye","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2011.04.027_bib0015","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1749-6632.2001.tb11364.x","article-title":"The burden of drug-resistant tuberculosis and mechanisms for its control","volume":"953","author":"Raviglione","year":"2001","journal-title":"Annals NY Acad Sci"},{"issue":"4","key":"10.1016\/j.vaccine.2011.04.027_bib0020","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ccm.2009.08.017","article-title":"Global burden and epidemiology of tuberculosis","volume":"30","author":"Glaziou","year":"2009","journal-title":"Clin Chest Med"},{"issue":"1","key":"10.1016\/j.vaccine.2011.04.027_bib0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0966-842X(01)02277-6","article-title":"Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains","volume":"10","author":"Bifani","year":"2002","journal-title":"Trends Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2011.04.027_bib0030","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1183\/09031936.00081909","article-title":"Totally drug-resistant tuberculosis strains: evidence of adaptation at the cellular level","volume":"34","author":"Velayati","year":"2009","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.vaccine.2011.04.027_bib0035","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1378\/chest.08-2427","article-title":"Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran","volume":"136","author":"Velayati","year":"2009","journal-title":"Chest"},{"issue":"9678","key":"10.1016\/j.vaccine.2011.04.027_bib0040","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(09)60331-7","article-title":"Epidemiology of antituberculosis drug resistance 2002\u20132007: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance","volume":"373","author":"Wright","year":"2009","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.vaccine.2011.04.027_bib0045","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1086\/424851","article-title":"Does tuberculosis increase HIV load?","volume":"190","author":"Day","year":"2004","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2011.04.027_bib0050","article-title":"Tuberculosis and HIV infection: the global setting","volume":"196","author":"Nunn","year":"2007","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2011.04.027_bib0055","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1086\/518665","article-title":"HIV infection and multidrug-resistant tuberculosis: the perfect storm","volume":"196","author":"Wells","year":"2007","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2011.04.027_bib0060","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2011.04.027_bib0065","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.vaccine.2005.07.078","article-title":"Preclinical testing of new vaccines for tuberculosis: a comprehensive review","volume":"24","author":"Orme","year":"2006","journal-title":"Vaccine"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2011.04.027_bib0070","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1086\/651489","article-title":"Update on research and development pipeline: tuberculosis vaccines","volume":"50","author":"Beresford","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2011.04.027_bib0075","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrmicro1419","article-title":"Advances in tuberculosis vaccine strategies","volume":"4","author":"Skeiky","year":"2006","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2011.04.027_bib0080","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.tube.2009.01.005","article-title":"Clinical strains of Mycobacterium tuberculosis display a wide range of virulence in guinea pigs","volume":"89","author":"Palanisamy","year":"2009","journal-title":"Tuberculosis (Edinb)"},{"issue":"1","key":"10.1016\/j.vaccine.2011.04.027_bib0085","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4049\/jimmunol.179.1.522","article-title":"The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation","volume":"179","author":"Ordway","year":"2007","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2011.04.027_bib0090","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2249.2006.03162.x","article-title":"The emergence of Beijing family genotypes of Mycobacterium tuberculosis and low-level protection by bacille Calmette-Guerin (BCG) vaccines: is there a link?","volume":"145","author":"Abebe","year":"2006","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2011.04.027_bib0095","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/nm765","article-title":"A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis","volume":"8","author":"Sambandamurthy","year":"2002","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.vaccine.2011.04.027_bib0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2249.2005.02832.x","article-title":"Immunogenicity and protective efficacy of the Mycobacterium tuberculosis fadD26 mutant","volume":"141","author":"Infante","year":"2005","journal-title":"Clin Exp Immunol"},{"issue":"6685","key":"10.1016\/j.vaccine.2011.04.027_bib0105","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/31159","article-title":"Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence","volume":"393","author":"Cole","year":"1998","journal-title":"Nature"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2011.04.027_bib0110","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.micinf.2005.04.001","article-title":"Live attenuated mutants of Mycobacterium tuberculosis as candidate vaccines against tuberculosis","volume":"7","author":"Sambandamurthy","year":"2005","journal-title":"Microbes Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2011.04.027_bib0115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1517\/14712598.8.2.201","article-title":"Live tuberculosis vaccines based on phoP mutants: a step towards clinical trials","volume":"8","author":"Asensio","year":"2008","journal-title":"Expert Opin Biol Ther"},{"issue":"18","key":"10.1016\/j.vaccine.2011.04.027_bib0120","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/j.vaccine.2009.02.060","article-title":"Extended safety studies of the attenuated live tuberculosis vaccine SO2 based on phoP mutant","volume":"27","author":"Cardona","year":"2009","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2011.04.027_bib0125","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1128\/IAI.73.4.2379-2386.2005","article-title":"Generation of attenuated Mycobacterium bovis strains by signature-tagged mutagenesis for discovery of novel vaccine candidates","volume":"73","author":"Collins","year":"2005","journal-title":"Infect Immun"},{"issue":"5127","key":"10.1016\/j.vaccine.2011.04.027_bib0130","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1126\/science.8367727","article-title":"Cloning of an M. tuberculosis DNA fragment associated with entry and survival inside cells","volume":"261","author":"Arruda","year":"1993","journal-title":"Science"},{"issue":"13","key":"10.1016\/j.vaccine.2011.04.027_bib0135","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.vaccine.2005.11.051","article-title":"Immunogenicity and protection induced by Mycobacterium tuberculosis mce-2 and mce-3 mutants in a Balb\/c mouse model of progressive pulmonary tuberculosis","volume":"24","author":"Aguilar","year":"2006","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2011.04.027_bib0140","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.micinf.2004.11.007","article-title":"Mutation in mce operons attenuates Mycobacterium tuberculosis virulence","volume":"7","author":"Gioffre","year":"2005","journal-title":"Microbes Infect"},{"issue":"11","key":"10.1016\/j.vaccine.2011.04.027_bib0145","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.micinf.2007.05.020","article-title":"Enhanced mortality despite control of lung infection in mice aerogenically infected with a Mycobacterium tuberculosis mce1 operon mutant","volume":"9","author":"Lima","year":"2007","journal-title":"Microbes Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2011.04.027_bib0150","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.tube.2009.10.004","article-title":"Mce2 operon mutant strain of Mycobacterium tuberculosis is attenuated in C57BL\/6 mice","volume":"90","author":"Marjanovic","year":"2010","journal-title":"Tuberculosis (Edinb)"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2011.04.027_bib0155","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1099\/jmm.0.47454-0","article-title":"Mycobacterium tuberculosis strains disrupted in mce3 and mce4 operons are attenuated in mice","volume":"57","author":"Senaratne","year":"2008","journal-title":"J Med Microbiol"},{"issue":"26","key":"10.1016\/j.vaccine.2011.04.027_bib0160","doi-asserted-by":"crossref","first-page":"15918","DOI":"10.1073\/pnas.2433882100","article-title":"Hypervirulent mutant of Mycobacterium tuberculosis resulting from disruption of the mce1 operon","volume":"100","author":"Shimono","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2011.04.027_bib0165","doi-asserted-by":"crossref","unstructured":"Cheigh CI, Senaratne R, Uchida Y, Casali N, Kendall LV, Riley LW. Posttreatment reactivation of tuberculosis in mice caused by Mycobacterium tuberculosis disrupted in mce1R. J Infect Dis; 202(5):752-9.","DOI":"10.1086\/655224"},{"issue":"10","key":"10.1016\/j.vaccine.2011.04.027_bib0170","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.1128\/IAI.72.10.5963-5971.2004","article-title":"Magnetic resonance imaging of pulmonary lesions in guinea pigs infected with Mycobacterium tuberculosis","volume":"72","author":"Kraft","year":"2004","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2011.04.027_bib0175","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.tube.2005.11.003","article-title":"Lymphadenitis as a major element of disease in the guinea pig model of tuberculosis","volume":"86","author":"Basaraba","year":"2006","journal-title":"Tuberculosis (Edinb)"},{"issue":"5","key":"10.1016\/j.vaccine.2011.04.027_bib0180","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1128\/AAC.01521-09","article-title":"Evaluation of standard chemotherapy in the guinea pig model of tuberculosis","volume":"54","author":"Ordway","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.vaccine.2011.04.027_bib0185","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.tube.2010.06.002","article-title":"The Achilles heel of BCG","volume":"90","author":"Orme","year":"2010","journal-title":"Tuberculosis (Edinb)"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2011.04.027_bib0190","volume":"88","author":"Basaraba","year":"2008","journal-title":"Experimental tuberculosis: the role of comparative pathology in the discovery of improved tuberculosis treatment strategies. Tuberculosis (Edinb)"},{"issue":"8","key":"10.1016\/j.vaccine.2011.04.027_bib0195","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1172\/JCI31947","article-title":"Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis","volume":"117","author":"Hinchey","year":"2007","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.vaccine.2011.04.027_bib0200","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1574-6968.1999.tb13738.x","article-title":"Disruption of the mycobacterial cell entry gene of Mycobacterium bovis BCG results in a mutant that exhibits a reduced invasiveness for epithelial cells","volume":"177","author":"Flesselles","year":"1999","journal-title":"FEMS Microbiol Lett"},{"issue":"22","key":"10.1016\/j.vaccine.2011.04.027_bib0205","doi-asserted-by":"crossref","first-page":"12989","DOI":"10.1073\/pnas.2134250100","article-title":"Genetic requirements for mycobacterial survival during infection","volume":"100","author":"Sassetti","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.vaccine.2011.04.027_bib0210","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1086\/651452","article-title":"Attenuation of Mycobacterium tuberculosis functionally disrupted in a fatty acyl-coenzyme A synthetase gene fadD5","volume":"201","author":"Dunphy","year":"2010","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2011.04.027_bib0215","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1128\/CVI.00368-09","article-title":"Phenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with Mycobacterium tuberculosis","volume":"17","author":"Henao-Tamayo","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2011.04.027_bib0220","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.tube.2007.12.003","article-title":"Disseminated disease severity as a measure of virulence of Mycobacterium tuberculosis in the guinea pig model","volume":"88","author":"Palanisamy","year":"2008","journal-title":"Tuberculosis (Edinb)"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2011.04.027_bib0225","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tube.2004.09.015","article-title":"Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials","volume":"85","author":"McShane","year":"2005","journal-title":"Tuberculosis (Edinb)"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11005627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11005627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T05:26:21Z","timestamp":1543814781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11005627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":45,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0264410X11005627"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.04.027","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}